Managing metastatic Crohn's disease : a single center experience, review of the current evidence, and treatment algorithm
BACKGROUND: Crohn's disease (CD) is an inflammatory bowel disease (IBD) that, besides gastrointestinal symptoms, may encompass extra-intestinal symptoms, such as dermatological manifestations. Of those, metastatic CD (MCD) is a rare extra-intestinal manifestation for which the management is uncertain.
METHODS: We conducted a retrospective case series of patients with MCD seen at the University hospital Leuven, Belgium, combined with an overview of the recent literature. Electronic medical records were searched from January 2003 till April 2022. For the literature search, Medline, Embase, Trip Database, and The Cochrane Library were searched from inception to April 1, 2022.
RESULTS: A total of 11 patients with MCD were retrieved. In all cases noncaseating granulomatous inflammation was found on skin biopsies. Two adults and one child were diagnosed with MCD prior to their diagnosis of CD. Seven patients were treated with steroids (intralesional, topical or systemic). Six patients needed a biological therapy to treat MCD. Surgical excision was performed in three patients. All patients reported a successful outcome and most cases achieved remission. The literature search yielded 53 articles, including three reviews, three systematic reviews, 30 case reports and six case series. A treatment algorithm was generated based on literature and multidisciplinary discussion.
CONCLUSION: MCD remains a rare entity and diagnosis is often difficult. A multidisciplinary approach including skin biopsy is necessary to diagnose and treat MCD efficiently. Outcome is generally favorable, and lesions respond well to steroids and biologicals. We propose a treatment algorithm based on the available evidence and multidisciplinary discussion.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
---|---|
Enthalten in: |
Scandinavian journal of gastroenterology - 58(2023), 10 vom: 07. Juli, Seite 1122-1130 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Beysens, S [VerfasserIn] |
---|
Links: |
---|
Themen: |
Crohn’s disease |
---|
Anmerkungen: |
Date Completed 02.11.2023 Date Revised 03.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/00365521.2023.2209689 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM356807843 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM356807843 | ||
003 | DE-627 | ||
005 | 20231226071240.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/00365521.2023.2209689 |2 doi | |
028 | 5 | 2 | |a pubmed24n1189.xml |
035 | |a (DE-627)NLM356807843 | ||
035 | |a (NLM)37178009 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Beysens, S |e verfasserin |4 aut | |
245 | 1 | 0 | |a Managing metastatic Crohn's disease |b a single center experience, review of the current evidence, and treatment algorithm |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.11.2023 | ||
500 | |a Date Revised 03.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Crohn's disease (CD) is an inflammatory bowel disease (IBD) that, besides gastrointestinal symptoms, may encompass extra-intestinal symptoms, such as dermatological manifestations. Of those, metastatic CD (MCD) is a rare extra-intestinal manifestation for which the management is uncertain | ||
520 | |a METHODS: We conducted a retrospective case series of patients with MCD seen at the University hospital Leuven, Belgium, combined with an overview of the recent literature. Electronic medical records were searched from January 2003 till April 2022. For the literature search, Medline, Embase, Trip Database, and The Cochrane Library were searched from inception to April 1, 2022 | ||
520 | |a RESULTS: A total of 11 patients with MCD were retrieved. In all cases noncaseating granulomatous inflammation was found on skin biopsies. Two adults and one child were diagnosed with MCD prior to their diagnosis of CD. Seven patients were treated with steroids (intralesional, topical or systemic). Six patients needed a biological therapy to treat MCD. Surgical excision was performed in three patients. All patients reported a successful outcome and most cases achieved remission. The literature search yielded 53 articles, including three reviews, three systematic reviews, 30 case reports and six case series. A treatment algorithm was generated based on literature and multidisciplinary discussion | ||
520 | |a CONCLUSION: MCD remains a rare entity and diagnosis is often difficult. A multidisciplinary approach including skin biopsy is necessary to diagnose and treat MCD efficiently. Outcome is generally favorable, and lesions respond well to steroids and biologicals. We propose a treatment algorithm based on the available evidence and multidisciplinary discussion | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Crohn’s disease | |
650 | 4 | |a IBD-clinical | |
650 | 4 | |a Metastatic Crohn’s disease | |
650 | 4 | |a extraintestinal manifestations | |
650 | 4 | |a noncaseating granulomas | |
650 | 7 | |a Steroids |2 NLM | |
700 | 1 | |a Wellens, J |e verfasserin |4 aut | |
700 | 1 | |a De Hertogh, G |e verfasserin |4 aut | |
700 | 1 | |a Van Laethem, A |e verfasserin |4 aut | |
700 | 1 | |a Sabino, J |e verfasserin |4 aut | |
700 | 1 | |a Hillary, T |e verfasserin |4 aut | |
700 | 1 | |a Vermeire, S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Scandinavian journal of gastroenterology |d 1966 |g 58(2023), 10 vom: 07. Juli, Seite 1122-1130 |w (DE-627)NLM000055166 |x 1502-7708 |7 nnns |
773 | 1 | 8 | |g volume:58 |g year:2023 |g number:10 |g day:07 |g month:07 |g pages:1122-1130 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/00365521.2023.2209689 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 58 |j 2023 |e 10 |b 07 |c 07 |h 1122-1130 |